Andy Hsieh
Stock Analyst at William Blair
(2.95)
# 1,227
Out of 5,182 analysts
9
Total ratings
66.67%
Success rate
61.97%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Andy Hsieh
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| AARD Aardvark Therapeutics | Initiates: Outperform | n/a | $5.44 | - | 1 | Dec 12, 2025 | |
| CRBP Corbus Pharmaceuticals Holdings | Initiates: Outperform | n/a | $10.96 | - | 1 | Feb 28, 2025 | |
| SKYE Skye Bioscience | Initiates: Outperform | n/a | $0.86 | - | 1 | Feb 28, 2025 | |
| ALT Altimmune | Initiates: Market Perform | n/a | $3.09 | - | 1 | Feb 28, 2025 | |
| GPCR Structure Therapeutics | Initiates: Outperform | n/a | $39.10 | - | 1 | Feb 28, 2025 | |
| BIOA BioAge Labs | Initiates: Market Perform | n/a | $17.99 | - | 1 | Feb 28, 2025 | |
| PYXS Pyxis Oncology | Downgrades: Market Perform | n/a | $2.74 | - | 1 | Nov 21, 2024 | |
| LNTH Lantheus Holdings | Initiates: Outperform | n/a | $93.06 | - | 1 | Sep 29, 2023 | |
| ATNM Actinium Pharmaceuticals | Downgrades: Market Perform | n/a | $1.31 | - | 1 | Feb 21, 2023 |
Aardvark Therapeutics
Dec 12, 2025
Initiates: Outperform
Price Target: n/a
Current: $5.44
Upside: -
Corbus Pharmaceuticals Holdings
Feb 28, 2025
Initiates: Outperform
Price Target: n/a
Current: $10.96
Upside: -
Skye Bioscience
Feb 28, 2025
Initiates: Outperform
Price Target: n/a
Current: $0.86
Upside: -
Altimmune
Feb 28, 2025
Initiates: Market Perform
Price Target: n/a
Current: $3.09
Upside: -
Structure Therapeutics
Feb 28, 2025
Initiates: Outperform
Price Target: n/a
Current: $39.10
Upside: -
BioAge Labs
Feb 28, 2025
Initiates: Market Perform
Price Target: n/a
Current: $17.99
Upside: -
Pyxis Oncology
Nov 21, 2024
Downgrades: Market Perform
Price Target: n/a
Current: $2.74
Upside: -
Lantheus Holdings
Sep 29, 2023
Initiates: Outperform
Price Target: n/a
Current: $93.06
Upside: -
Actinium Pharmaceuticals
Feb 21, 2023
Downgrades: Market Perform
Price Target: n/a
Current: $1.31
Upside: -